FDA Investigator Charlotte E Wilkins
Charlotte E Wilkins has inspections in 1 countries as of 24 Apr 2023. Charlotte E Wilkins has collaborated with a combined 1096 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
50
Last Inspection Date:
24 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amos C Epps,
Amy C Amaro,
Brandon J Brookens,
Brian S Keefer,
Bromley,
Bruce E Kummer,
Bryan J Love,
Cara M Minelli,
Charlean R Butler,
Christina K Theodorou,
Christine M O'leary,
Conrad M Guardia,
Craig D Zagata,
Crayton Lee,
Daniel T Lee,
David J Hafner,
Decima L Washington,
Dianne H Milazzo,
Dirk L Lincoln,
Douglas A Campbell,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Edward P Potter,
Elvis D Morton,
Esaw,
Esther C Broner, PhD,
Gale L Glinecki,
Gerald Mierle,
Gerald W Kopp,
Gifford Whitehurst, Jr,
Hamilton,
Heath A Gerber,
Hector J Colon Torres,
Jacqueline Johnson,
James M Mason,
Jessica S Estriplet,
Jose R Hernandez,
Karen A Spencer,
Kenneth L Smalls,
Kenneth Nieves,
Laurianne M Montonye,
LCDR Wilfred A Darang,
Linda J Eason,
Marla A Cassidy,
Mary K Leslie,
Mary P Ross,
Maureen A Wentzel,
Michael A Taylor,
Michael S Call,
Pelekakis,
Sean R Moynihan, MPH,
Sierra M Shockley,
Slatten,
State Agency,
Stephen C Eason,
Sullivanm,
Susan F Laska, MS,
Sylvia R Dooling,
Tamara N Champion,
Thomas,
Thomas J Hudson,
Travers,
Vlada Matusovsky,
William H Linkroum,
Yvins Dezan,
Zhong Li, PhD
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more